Meeting
2023 ASCO Genitourinary Cancers Symposium
Oncologic outcomes following post-cystectomy recurrence of bladder cancer based on metastatic site and role of salvage immunotherapy.
Authors
Seyedeh Sanam Ladi Seyedian
Department of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
Seyedeh Sanam Ladi Seyedian , Chirag Doshi , Luis Santos Molina , Erika Wood , Jie Cai , Gus Miranda , Anne K. Schuckman , Hooman Djaladat , Siamak Daneshmand
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Other
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 574)
DOI
10.1200/JCO.2023.41.6_suppl.574
Abstract #
574
Poster Bd #
N17
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Survival outcomes associated with different palliative systemic therapies (PSTs) in patients with metastatic bladder cancer (mBC).
First Author: Saba Vafaei-Nodeh
Poster
2024 ASCO Genitourinary Cancers Symposium
AI-based morphologic model for prediction of individual patient response to immune checkpoint inhibitors for bladder cancer.
First Author: Monica Nair
Poster
2023 ASCO Annual Meeting
Advanced cervical cancer therapy: Comparison of contemporary expert and healthcare professional recommendations from an online treatment decision tool.
First Author: Lauren S. Prescott
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The optimal extent of lymph node dissection for gastric cancer with para-aortic lymph node metastases.
First Author: Takeyuki Wada